Mar 02, 2021 8:30am EST Veru to Participate in Fireside Chat at the H.C. Wainwright Global Life Sciences Conference
Mar 01, 2021 8:30am EST Veru Receives FDA Agreement to Advance VERU-111 into Phase 3 Study in Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS)
Feb 10, 2021 6:30am EST Veru Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2021 First Quarter
Feb 08, 2021 7:30am EST Veru Reports Positive Phase 2 Clinical Results of VERU-111 in Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome
Jan 27, 2021 8:30am EST Veru to Report Fiscal 2021 First-Quarter Financial Results, Host Conference Call on February 10th
